4.6 Article

Antidiabetes constituents, cycloartenol and 24-methylenecycloartanol, fromFicus krishnae

Journal

PLOS ONE
Volume 15, Issue 6, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0235221

Keywords

-

Funding

  1. Plan Project programme of the Government of Kerala, India [P007]
  2. Science and Engineering Research Board (SERB), Government of India [CRG/2019/000131]

Ask authors/readers for more resources

Ficus krishnaestem bark and leaves are used for diabetes treatment in traditional medicines. Stem bark ofF.krishnaewas sequentially extracted with hexane, methanol and water, and these extracts were tested for their antihyperglyceamic activity by oral glucose tolerance test (OGTT) in overnight fasted glucose loaded normal rats. Hexane extract showed significant glucose lowering activity in OGTT, and the triterpene alcohols (cycloartenol+24-methylenecycloartanol) (CA+24-MCA) were isolated together from it by activity guided isolation and characterized by NMR and mass spectroscopy. The ratio of the chemical constituents CA and 24-MCA in (CA+24-MCA) was determined as 2.27:1.00 by chemical derivatization and gas chromatographic quantification. (CA+24-MCA) in high fat diet-streptozotocin induced type II diabetic rats showed significant antidiabetes activity at 1 mg/kg and ameliorated derailed blood glucose and other serum biochemical parameters. Cytoprotective activity of (CA+24-MCA) from glucose toxicity was evaluated in cultured RIN-5F cells by MTT assay and fluorescent microscopy. (CA+24-MCA) inin vitrostudies showed enhanced cell viability in RIN-5F cells and significant protection of beta cells from glucose toxicity. Both inin vivoandin vitrostudies (CA+24-MCA) showed enhancement in insulin release from the beta cells. In short term toxicity studies in mice (CA+24-MCA) did not show any conspicuous toxic symptoms. The combination of the phytosterols (CA+24-MCA) obtained through activity guided isolation of the stem bark ofF.krishnaeshowed significant activity, and therefore is a promising candidate for new generation antidiabetes drug development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available